FORME POLYMORPHE DE L'ACIDE 4-{[4-({[4-(2,2,2-TRIFLUOROÉTHOXY)- 1,2-BENZISOXAZOL-3-YL]OXY}MÉTHYL)PIPÉRIDIN-1-YL]MÉTHYL}-TÉTRAHYDRO-2H-PYRAN-4-CARBOXYLIQUE
The present invention relates to novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. More particularly, the invention relates to polymorph forms (Polymorph Form I or Polymorph Form II), and to processes for the preparation of, compositions containing and to uses of, such polymorph forms.
